Middle East And Africa Cardiovascular Ultrasound Market 2022-2028
MARKET OUTLOOK
Triton Market Research’s report on the cardiovascular ultrasound market in the Middle East and Africa puts forth that it would grow with a CAGR of 6.31% in the forecast period 2022-2028. Saudi Arabia, Turkey, the United Arab Emirates, South Africa, and Rest of Middle East & Africa are scrutinized in the market in this region.
According to estimates, cardiovascular disease (CVD) accounts for nearly 42% of all mortalities in Saudi Arabia. The risk factors for CVD can be classified into two sections: modifiable factors like obesity, hypertension, diabetes, dyslipidemia, and smoking, and non-modifiable factors like ethnicity, age, and family history.
A staggering 55.5% of the Saudi Arabian population is either hypertensive or pre-hypertensive; whereas, 20.2% of the population is diabetic. Awareness of CVD and its risk factors is critical in order to encourage people to adopt a healthier lifestyle. This, in turn, has boosted the use of cardiovascular ultrasound systems in the country, and is expected to drive the market growth in the forthcoming years.
At a mortality rate of 47%, cardiovascular disease accounts for nearly half of all deaths in Turkey. In 2020, close to 85,905 people lost their lives due to coronary heart disease in the country. However, Turkey has also been successful in managing these conditions by increasing the availability of percutaneous cardiac interventions for its citizens. This has promoted the adoption of echocardiography systems. The rising adoption is expected to lead the Turkish market on a growth path.
COMPETITIVE OUTLOOK
The notable players in the cardiovascular ultrasound market include Lanmage, Samsung Medison Co Ltd, Mindray Medical International Limited, Esaote S.p.A., Canon Medical Corp, GE Healthcare, Viatom Technology Co, and Philips Healthcare.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook